ChartMill · Mar 2, 2026
Monday's session: top gainers and losers
Let's have a look at what is happening on the US markets in the middle of the day on Monday. Below you can find the top gainers and losers in today's session.
NASDAQ · CDIO
Healthcare · Biotechnology
$1.85
Down-$0.02 (-1.31%)
Updated Aug 29, 2026, 3:56 AM
SID Score
4.2/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance
1M range · 21 trading sessions · Daily adjusted prices
CDIO closed at $1.85 after 21 trading sessions, up 18.59% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 28, 2026 | $1.90 | $1.90 | $1.81 | $1.85 | 14.13K |
| Aug 27, 2026 | $1.92 | $1.92 | $1.85 | $1.87 | 24.24K |
| Aug 26, 2026 | $1.93 | $1.9499 | $1.8062 | $1.93 | 25.83K |
| Aug 25, 2026 | $1.89 | $2.00 | $1.86 | $1.91 | 26.3K |
| Aug 24, 2026 | $2.03 | $2.1699 | $1.88 | $1.925 | 51.71K |
| Aug 21, 2026 | $2.19 | $2.19 | $1.9601 | $2.03 | 36.87K |
| Aug 20, 2026 | $1.99 | $2.28 | $1.9204 | $2.21 | 57.14K |
| Aug 19, 2026 | $1.89 | $2.04 | $1.86 | $1.99 | 48.98K |
| Aug 18, 2026 | $2.00 | $2.0099 | $1.7673 | $1.91 | 48.88K |
| Aug 17, 2026 | $2.00 | $2.10 | $1.98 | $1.99 | 39.56K |
| Aug 14, 2026 | $2.00 | $2.1049 | $1.98 | $2.04 | 46.75K |
| Aug 13, 2026 | $2.33 | $2.34 | $2.01 | $2.01 | 184.38K |
| Aug 12, 2026 | $1.9799 | $2.25 | $1.93 | $2.16 | 267.94K |
| Aug 11, 2026 | $1.75 | $1.96 | $1.58 | $1.83 | 55.5K |
| Aug 10, 2026 | $1.81 | $1.83 | $1.71 | $1.71 | 15.04K |
| Aug 7, 2026 | $1.5735 | $1.80 | $1.5735 | $1.79 | 6.43K |
| Aug 6, 2026 | $1.74 | $1.75 | $1.66 | $1.66 | 13.36K |
| Aug 5, 2026 | $1.732 | $1.79 | $1.73 | $1.75 | 25.42K |
| Aug 4, 2026 | $1.67 | $1.7746 | $1.60 | $1.74 | 32.08K |
| Aug 3, 2026 | $1.57 | $1.69 | $1.565 | $1.64 | 25.76K |
| Jul 31, 2026 | $1.5796 | $1.60 | $1.54 | $1.56 | 12.93K |
The latest Smart Investors Daily articles mentioning CDIO.
CDIO research
Company profile and research snapshot.
Cardio Diagnostics Holdings Inc is a medical technology company focused on developing and commercializing epigenetics-based clinical tests for cardiovascular diseases. The company offers three AI-powered solutions for the risk assessment, detection, management, and monitoring of coronary heart diseases. These solutions are Epi+Gen CHD, a symptomatic CHD risk assessment clinical blood test targeting CHD events; PrecisionCHD, an integrated epigenetic-genetic clinical blood test for the detection of coronary heart disease; and Actionable Clinical Intelligence, a platform coupled to the Epi+Gen CHD and PrecisionCHD tests that provide personalized insights by linking the epigenetic and genetic biomarkers evaluated by these tests to the drivers of coronary heart disease.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Aug 27, 2024 | Benchmark | Speculative Buy | — |
| Jun 6, 2024 | Benchmark | Speculative Buy | — |
| Apr 19, 2024 | Benchmark | Speculative Buy | — |
| Jun 15, 2023 | Benchmark | Speculative Buy | — |
| May 22, 2023 | Northland Capital Markets | Outperform | — |
No generated briefing is available yet.
ChartMill · Mar 2, 2026
Let's have a look at what is happening on the US markets in the middle of the day on Monday. Below you can find the top gainers and losers in today's session.
Benzinga · Mar 2, 2026
ChartMill · Feb 27, 2026
Looking for insights into the US markets one hour before the close of the markets on Friday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.
ChartMill · Feb 27, 2026
Let's explore the current happenings on the US markets on Friday. Below, you'll find the stocks exhibiting unusual volume in today's session.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.


The latest Smart Investors Daily articles mentioning CDIO.